Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Recruiting

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

NCT04741997

Conditions: BRAF V600 Mutation, Melanoma, Melanoma Stage III, +12 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Recruiting

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

NCT06956690

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations: Research Site La Jolla, California, United States

Research Site Indianapolis, Indiana, United States

Research Site Farmington Hills, Michigan, United States

Research Site Dallas, Texas, United States

View Trial Details

Recruiting

In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma

NCT05636540

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

NCT06070012

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Promoting Immunotherapy Efficacy With Low-Dose Liver RT

NCT07225036

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
Locations: University of Cincinnati Medical Center Cincinnati, Ohio, United States

View Trial Details

Recruiting

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

NCT05549297

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +13 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

Mayo Clinic Florida Jacksonville, Florida, United States

Orlando Health Cancer Institute Orlando, Florida, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

View all 82 locations

View Trial Details

Recruiting

Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

NCT06627244

Conditions: Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia

NCT07422779

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

NCT04354064

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +51 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

NCT06305962

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +46 more
Locations: Nepean Hospital Kingswood, New South Wales, Australia

Wollongong Hospital Wollongong, New South Wales, Australia

Gold Coast University Hospital Southport, Queensland, Australia

Cancer Research SA (CRSA) Adelaide, South Australia, Australia

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions